Patent 11014908 was granted and assigned to Pfizer Limited on May, 2021 by the United States Patent and Trademark Office.
The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.